PhD in Toxicology, Faculté de Pharmacie, Université d’Auvergne, Clermont-Ferrand, France, 2005
Associate Professor and Hospital practitioner, Laboratoire de Toxicologie, Université d’Auvergne, Clermont-Ferrand, France
-
Balayssac, D., Pereira, B., Bazin, J. E., Le Roy, B., Pezet, D. and Gagniere, J. (2016). Warmed and humidified carbon dioxide for abdominal laparoscopic surgery: meta-analysis of the current literature. Surg Endosc.
-
Le Roy, B., Tixier, L., Pereira, B., Sauvanet, P., Buc, E., Petorin, C., Dechelotte, P., Pezet, D. and Balayssac, D. (2016). Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study. PLoS One 11(2): e0148739.
-
Ferrier, J., Bayet-Robert, M., Dalmann, R., El Guerrab, A., Aissouni, Y., Graveron-Demilly, D., Chalus, M., Pinguet, J., Eschalier, A., Richard, D., Daulhac, L., Marchand, F. and Balayssac, D. (2015). Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception. J Neurosci 35(50): 16418-16430.
-
Dubois, A., Carrier, G., Pereira, B., Gillet, B., Faucheron, J. L., Pezet, D. and Balayssac, D. (2015). Therapeutic management of complex anal fistulas by installing a nitinol closure clip: study protocol of a multicentric randomised controlled trial--FISCLOSE. BMJ Open 5(12): e009884.
-
Poupon, L., Kerckhove, N., Vein, J., Lamoine, S., Authier, N., Busserolles, J. and Balayssac, D. (2015). Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives. Expert Opin Drug Saf 14(8): 1269-1282.
-
Paul, C., Zenut, M., Dorut, A., Coudore, M. A., Vein, J., Cardot, J. M. and Balayssac, D. (2015). Response to "Use of domperidone to increase breast milk supply: further consideration of the benefit-risk ratio is required". J Hum Lact 31(2): 316-317.
-
Balayssac, D., Ferrier, J., Pereira, B., Gillet, B., Petorin, C., Vein, J., Libert, F., Eschalier, A. and Pezet, D. (2015). Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial. BMJ Open 5(4): e007479.
-
Paul, C., Zenut, M., Dorut, A., Coudore, M. A., Vein, J., Cardot, J. M. and Balayssac, D. (2015). Use of domperidone as a galactagogue drug: a systematic review of the benefit-risk ratio. J Hum Lact 31(1): 57-63.
-
Balayssac, D., Ling, B., Ferrier, J., Pereira, B., Eschalier, A. and Authier, N. (2014). Assessment of thermal sensitivity in rats using the thermal place preference test: description and application in the study of oxaliplatin-induced acute thermal hypersensitivity and inflammatory pain models. Behav Pharmacol 25(2): 99-111.
-
Ferrier, J., Bayet-Robert, M., Pereira, B., Daulhac, L., Eschalier, A., Pezet, D., Moulinoux, J. P. and Balayssac, D. (2013). A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in rats. PLoS One 8(10): e77828.
-
Ferrier, J., Pereira, V., Busserolles, J., Authier, N. and Balayssac, D. (2013). Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 17(10): 364.
-
Balayssac, D., Poinas, A. C., Pereira, B. and Pezet, D. (2013). Use of permacol in parietal and general surgery: a bibliographic review. Surg Innov 20(2): 176-182.
-
Balayssac, D., Ferrier, J., Descoeur, J., Ling, B., Pezet, D., Eschalier, A. and Authier, N. (2011). Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence. Expert Opin Drug Saf 10(3): 407-417.
-
Authier, N., Balayssac, D., Sautereau, M., Zangarelli, A., Courty, P., Somogyi, A. A., Vennat, B., Llorca, P. M. and Eschalier, A. (2009). Benzodiazepine dependence: focus on withdrawal syndrome. Ann Pharm Fr 67(6): 408-413.
-
Authier, N., Balayssac, D., Marchand, F., Ling, B., Zangarelli, A., Descoeur, J., Coudore, F., Bourinet, E. and Eschalier, A. (2009). Animal models of chemotherapy-evoked painful peripheral neuropathies. Neurotherapeutics 6(4): 620-629.
-
Balayssac, D., Cayre, A., Ling, B., Maublant, J., Penault-Llorca, F., Eschalier, A., Coudore, F. and Authier, N. (2009). Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy. Neurosci Lett 465(1): 108-112.
-
Balayssac, D., Cayre, A., Ling, B., Maublant, J., Penault-Llorca, F., Eschalier, A., Coudore, F. and Authier, N. (2008). Vincristine-induced neuropathy in the rat is not modified by drug-drug interactions with the P-glycoprotein inhibitor verapamil. Chemotherapy 54(5): 336-342.
-
Balayssac, D., Zangarelli, A. and Authier, N. (2008). Association of cannabis smoking and periodontal disease. JAMA 299(19): 2273; author reply 2273-2274.
-
Ling, B., Coudore-Civiale, M. A., Balayssac, D., Eschalier, A., Coudore, F. and Authier, N. (2007). Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat. Toxicology 234(3): 176-184.
-
Ling, B., Authier, N., Balayssac, D., Eschalier, A. and Coudore, F. (2007). Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain 128(3): 225-234.
-
Balayssac, D., Cayre, A., Authier, N., Ling, B., Maublant, J., Eschalier, A., Penault-Llorca, F. and Coudore, F. (2006). Involvement of the multidrug resistance transporters in cisplatin-induced neuropathy in rats. Comparison with the chronic constriction injury model and monoarthritic rats. Eur J Pharmacol 544(1-3): 49-57.
-
Ling, B., Authier, N., Balayssac, D., Eschalier, A. and Coudore, F. (2005). Assessment of nociception in acrylamide-induced neuropathy in rats. Pain 119(1-3): 104-112.
-
Balayssac, D., Cayre, A., Authier, N., Bourdu, S., Penault-Llorca, F., Gillet, J. P., Maublant, J., Eschalier, A. and Coudore, F. (2005). Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats. J Peripher Nerv Syst 10(3): 301-310.
-
Balayssac, D., Authier, N., Cayre, A. and Coudore, F. (2005). Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicol Lett 156(3): 319-329.